Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
Publication date
2005
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Citation
Wensing, A M J, van de Vijver, D A M C, Augarano, G, Asjo, B, Balotta, C, Boeri, E, Camacho, R, Chaix, M L, Costagliola, D, De Luca, A, Derdelinckx, I, Grosman, Z, Hamouda, O, Hatzakis, A, Hemmer, R, Hoepelman, I M, Horban, A, Korn, K, Kucherer, C, Leitner, T, Loveday, C, MacRae, E, Malikovic, I, Mendoza, C, Meyer, L, Nielsen, C, Op de Coul, E L, Ormaassen, V, Paraskevis, D, Perrin, L, Puchhammer-Stockl, E, Ruiz, L, Salminen, M, Schmit, J C, Schneider, F, Schuurman, R, Soriano, E, Stanzak, G, Stanojevic, M, Vandamme, A M, Van Laethem, K, Violin, M, Wilbe, K, Yerly, S, Zazzi, M & Boucher, C A B 2005, 'Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management', Journal of Infectious Diseases, vol. 192, no. 6, pp. 958-966.